PLA2R与THSD7A:同一疾病的不同路径?
本文综述原发性膜性肾病两大主要自身抗原PLA2R和THSD7A的分子与临床特征,二者均为足细胞表达的跨膜糖蛋白并诱导IgG4优势的体液免疫应答,可用于诊断和监测;PLA2R表位数量可能决定疾病严重度,THSD7A型可能独特关联恶性肿瘤,其他自身抗原可能尚存。
要点
- PLA2R和THSD7A是原发性膜性肾病两大主要自身抗原,定义两个分子亚类。
- 两者均诱导IgG4优势的循环自身抗体,临床可用于诊断和监测。
- PLA2R靶向表位数量可能决定疾病严重度;THSD7A型可能独特关联恶性肿瘤。
核心结论
- PLA2R与THSD7A定义原发性膜性肾病的两个分子亚类,均诱导IgG4优势自身抗体并可用于临床诊断与监测。
- PLA2R靶向表位数量可能决定疾病严重度,THSD7A型可能独特关联恶性肿瘤。
- 原发性膜性肾病可能还存在其他自身抗原。
研究设计与样本
- 综述,检索范围未在原文中报告。
主要发现
- PLA2R和THSD7A均为足细胞表达的大型跨膜糖蛋白,均诱导IgG4优势的体液免疫应答并产生可用于临床诊断和监测的循环自身抗体。
- THSD7A的若干特征提示其可能参与黏附,但两种蛋白的生物学角色仍属推测。
- PLA2R相关膜性肾病最初发现与HLA-DQA1风险等位基因关联,后续研究将焦点转向HLA-DRB位点。
- PLA2R胞外部分已定义三个含体液表位的不同区域,靶向表位数量可能决定疾病严重度。
- THSD7A相关膜性肾病尚无类似表位信息,但该型可能独特关联恶性肿瘤。
临床怎么用
- PLA2R和THSD7A自身抗体可用于原发性膜性肾病的临床诊断和监测。
- PLA2R表位数量可能有助于判断疾病严重度。
- THSD7A相关膜性肾病患者需关注恶性肿瘤关联。
局限性
- PLA2R和THSD7A的生物学角色仍属推测。
- THSD7A相关膜性肾病尚无表位信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The phospholipase A2 receptor (PLA2R) and thrombospondin type-1 domain-containing 7A (THSD7A) are the two major autoantigens in primary membranous nephropathy (MN), and define two molecular subclasses of this disease. Both proteins are large transmembrane glycoproteins expressed by the podocyte, and both induce IgG4-predominant humoral immune responses that produce circulating autoantibodies that can be used clinically for diagnostic and monitoring purposes. The biologic roles of these proteins remain speculative, although several features of THSD7A suggest a role in adhesion. PLA2R-associated MN was initially found to associate with risk alleles within HLA-DQA1, but subsequent studies have shifted the focus to the HLA-DRB locus. Three distinct humoral epitope-containing regions have been defined within the extracellular portion of PLA2R, and it appears that the number of targeted epitopes may determine disease severity. Although similar information is not yet available for THSD7A-associated MN, this form of MN may have a unique association with malignancy. Finally, it appears likely that other autoantigens in primary MN exist. Although protocols similar to those that identified PLA2R and THSD7A may be successful in the identification of novel antigenic targets in MN, newer techniques such as laser-capture mass spectrometry or protein arrays may be helpful as well.
引用
- Beck LH. PLA2R and THSD7A: Disparate Paths to the Same Disease? J Am Soc Nephrol. 2017. PMID: 28674044. doi:10.1681/ASN.2017020178
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。